Akero Therapeutics (AKRO) Q3 2024 Earnings

Aug 9Confirmed
Q3 2023
Q4 2023
Q2 2024
Q3 2024
-0.99
-0.89
-0.78
-0.68

Details

Expected EPS
-0.829662
Actual EPS
-0.81
Surprise EPS
0.02
Surprise Percent
+2.37%

Description

⁨Akero Therapeutics⁩ (⁦AKRO⁩) has reported earnings of ⁦-0.81⁩ per share for ⁦Q3 2024⁩.

0 Comments

Share your thoughts